CTN Dissemination Library

Northeast Node: Innovations in Opioid Use Disorder Treatment (webinar)
2026-02-26 12:00 - 13:00 (America/New_York) | Webinar/Virtual
Join the Northeast Node for the next installment of their Science Series on February 26, 2026 (12-1pm ET)!
Presenter: Sarah Wakeman, MD
This session will review changes in the opioid overdose crisis and innovations in opioid use disorder treatment, including novel approaches to initiating buprenorphine, use of long-acting injectable buprenorphine, and strategies for methadone initiation in general medical settings.

Western States Node: Problems Initiating Buprenorphine Treatment Among Patients Using Fentanyl (CTN-0135)
2026-02-25 11:00 - 12:30 UTC | Webinar/Virtual
Join the CTN Western States Node and the Northwest and Pacific Southwest Addiction Technology Transfer Centers (ATTCs) for their next joint webinar!
In this session, Erin Winstanley, PhD (CTN Appalachian Node), will describe a NIDA Clinical Trials Network study, CTN-0135, examining clinician-reported challenges with initiating buprenorphine for people using fentanyl, including precipitated or prolonged withdrawal, patient reports that buprenorphine was ineffective, and patient preference for methadone. In response to these challenges, most clinicians surveyed reported modifying their standard induction protocols or patient counseling approaches. Clinicians treating larger patient volumes, seeing a high proportion of patients using fentanyl, or initiating treatment in non-inpatient settings were more likely to report difficulties starting patients on buprenorphine. Dr. Winstanley will present the study results and discuss their implications.
1.5 CME/CE credits available! For information about credit types and accreditation, as well as learning objectives for this session, download the webinar flyer.

CTN Primary Care SIG: Whole-Person Primary Care for People Who Use Methamphetamine: Hearts, Lungs, Bugs, and Brains
2026-01-26 12:00 - 13:00 (America/New_York) | Webinar/Virtual
The Primary Care SIG aims to engage primary care in research, develop substance use treatment interventions relevant to community-based practice, and promote the transfer of evidence-based results from substance use research into community-based practices.
In their next online meeting, Steven Shoptaw, PhD (UCLA) will present on “Whole-Person Primary Care for People Who Use Methamphetamine: Hearts, Lungs, Bugs, and Brains.”
Join Zoom Meeting
Meeting ID: 943 3434 2090
Passcode: [REDACTED]

CTN T&I SIG: A Scoping Review of Implementation Strategies to Reduce Stigma Toward People Who Use Substances in Healthcare Settings
2026-01-20 09:00 - 10:00 (America/Los_Angeles) | Webinar/Virtual
Join the CTN Translation & Implementation (T&I) SIG on January 20, 2026 (9-10am PT) for their next virtual meeting, featuring guest speakers Camille Cioffi, PhD (Oregon Research Institute, University of OR), and Bryan Hartzler, PhD (Addictions, Drug & Alcohol Institute, University of WA)!

Stigma toward people with substance use disorders (SUD) remains a major barrier to care. In their session, titled, “A Scoping Review of Implementation Strategies to Reduce Stigma Toward People Who Use Substances in Healthcare Settings,” Drs. Cioffi and Hartzler will describe the methods, results, and implications of a scoping review completed by the CTN T&I SIG Implementation Strategies Workgroup to identify and describe implementation strategies used to reduce stigmatizing attitudes toward people with SUD in healthcare settings.

View flyer (png) to learn more about the presenters.

To request a link for the meeting, contact Elena Rosenberg-Carlson: rosenbee@stanford.edu

18th Annual Conference on the Science of Dissemination and Implementation in Health
2025-12-14 - 2025-12-17 | Gaylord National Resort & Convention Center, 201 Waterfront St., National Harbor, MD, 20745, United States
This December, individuals on the frontlines of dissemination and implementation (D&I) science will convene to ensure that evidence is used to inform decisions that will improve the health of individuals and communities.
Through a combination of plenaries, concurrent sessions, poster presentations, and workshops, the 18th Annual Conference on the Science of Dissemination and Implementation in Health, co-hosted by the National Institutes of Health (NIH) and AcademyHealth, supports the collective understanding of the research agenda, puts forth new findings, and identifies research priorities to set the field up for the next decade.
2025 Conference Theme
Realizing the Benefits of Dissemination & Implementation Science
This year’s conference theme will address our existing and future efforts to maximize the benefits of D&I science. While our field has identified and tested a range of strategies to ensure the adoption, integration, sustainment, and spread of effective health interventions, less attention has been focused on the ultimate benefits of successful dissemination and implementation studies. The 18th Annual Science of D&I Conference will explore success stories, methodological advancements, challenges, and opportunities to realize the benefits of our science across health care, community, and public health systems.

CTN Youth SIG Webinar: Advancing Equity Through Implementation Science in Adolescent Substance Use Prevention
2025-11-21 11:00 - 12:00 (America/New_York) | Webinar/Virtual
Join the CTN Youth SIG for their next webinar, Friday, November 21, 2025 (11:00 a.m.–12:00 p.m. ET), featuring Cady Berkel on “Advancing Equity Through Implementation Science in Adolescent Substance Use Prevention.”
Presenter:
Cady Berkel, PhD
Associate Professor
College of Health Solutions
Arizona State University
Culturally and contextually grounded preventive interventions can address upstream risk and protective factors to improve equity, but only if they are implemented in systems that serve underrepresented groups. This presentation will share findings a program of community-based research conducted in partnership with multiple settings (e.g., pediatric primary care, family courts, corrections) to advance equitable access to evidence-based substance use prevention for adolescents and families. The talk will also discuss implementation science frameworks and designs to incorporate equity and accelerate the translation of research into practice.
About the speaker:
Dr. Cady Berkel is an Associate Professor in the College of Health Solutions at Arizona State University whose program of federally funded research focuses on advancing equitable access to evidence-based substance use prevention for adolescents and families. Her work to embed parenting interventions in primary care was recognized by NIDA’s Substance Use Prevention Services in Primary Care Challenge. She also serves in national leadership roles, including as a National Advisory Council member for SAMHSA’s Center for Substance Abuse Prevention, a Subject Matter Expert for the CDC’s Community Preventive Services Task Force review of substance use prevention, and Co-Chair of the Society for Prevention Research Standards of Evidence Task Force.
Register here

CTN T&I SIG: Partnering with Tribal Clinics to Culturally Center the Delivery of Medication Treatment for Opioid Use Disorder: Primary Outcomes from a Formative Implementation Study
2025-11-18 09:00 - 10:00 (America/Los_Angeles) | Webinar/Virtual
Join the CTN Translation & Implementation (T&I) SIG on November 18, 2025 (9-10am PT) for their next session: Partnering with Tribal Clinics to Culturally Center the Delivery of Medication Treatment for Opioid Use Disorder: Primary Outcomes from a Formative Implementation Study, presented by Aimee Campbell, PhD and Kamilla Venner, PhD.
American Indian/Alaska Native (AI/AN) people exhibit many cultural strengths and resiliencies, yet rates of opioid overdose mortality continue to be the highest of all racial/ethnic groups in the U.S. This presentation will describe the development and testing of an implementation intervention, in partnership with four AI/AN-serving clinics, to culturally center the delivery of MOUD in order to improve implementation outcomes.
See flyer for more details
Contact Elena Rosenberg-Carlson at rosenbee@stanford.edu for the meeting link or to join the CTN T&I SIG listserv.

Frontiers in Addiction Research: NIDA-NIAAA Mini-Convention
2025-11-14 | Marriott Marquis San Diego Marina, 333 W. Harbor Dr., San Diego, CA, United States
The National Institute on Drug Abuse (NIDA) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) invite you to the annual 2025 NIDA-NIAAA Frontiers in Addiction Research Mini-Convention. The Mini-Convention will be held as a one-day in-person meeting in San Diego, CA, on November 14, 2025. The annual NIDA-NIAAA Mini-Convention provides a forum for presentations and discussions of current topics in neuroscience and addiction research.

Health System Node: Lessons Learned About Treating Co-occurring Conditions Among Adults Receiving Substance Use Disorder Treatment
2025-11-06 10:00 - 11:00 (America/Los_Angeles) | Webinar/Virtual
Co-occurring mental health and physical problems are common among patients receiving treatment for substance use disorders. When present, these issues typically predict poorer functional and substance-related outcomes following treatment. This suggests that addressing co-occurring problems during an episode of substance use disorder treatment could significantly improve a wide range of outcomes. However, prior studies have yielded somewhat inconsistent results regarding the additional and/or synergistic benefits of treating co-occurring mental health and physical problems beyond the standard effects of substance use disorder treatment alone.

In this virtual seminar, Dr. Mark Ilgen will briefly review the results of three large-scale randomized trials that targeted distinct issues—chronic pain, suicide risk, and insomnia—commonly faced by patients in substance use disorder treatment. He will then discuss common themes across these studies, as well as potential lessons learned for clinicians and researchers interested in treating complex substance use disorder patients in real-world settings.

No registration required. Contact Morgan Ford for more information: morgan.ford@kp.org.

Website/link to join:
Join the Microsoft Teams Meeting here
Meeting ID: 250 658 877 216 6
Passcode: [REDACTED]

American Academy of Addiction Psychiatry (AAAP) Annual Meeting
2025-11-06 - 2025-11-09 | Fairmont San Francisco, 950 Mason St., San Francisco, CA, 94108, United States
This event provides the latest scientific developments in substance use disorders and co-occurring psychiatric disorders for psychiatrists, primary care physicians, and allied health professionals. The goal of the conference is to recognize emerging issues and trends in addiction psychiatry and be on the forefront of diagnosis and treatment of substance use disorders and co-occurring psychiatric disorders.

American Public Health Association (APHA) Annual Meeting
2025-11-02 - 2025-11-05 | Walter E. Washington Convention Center, 801 Allen Y. Lew Place NW, Washington, DC, 20001, United States
Each year, APHA’s Annual Meeting and Expo convenes about 12,000 public health professionals and partners from around the world to engage, collaborate and grow. The Annual Meeting brings together a broad spectrum of professionals across a variety of disciplines. As the largest public health gathering of the year, this is a meeting you won’t want to miss. Join AJPH this year to learn from your peers, hear from today’s leaders, network with exhibitors and make long-lasting connections.

GIN On the Rocks: Across the Continuum: Community-Engaged Research on Substance Use
2025-10-20 12:00 - 13:00 (America/Los_Angeles)
In this session, Jordan A. Dyett, PhD, LCSW, of the University of Wyoming, will outline the community-engaged research continuum and key methodological considerations for partnering with communities.
She will share examples from her research to illustrate different points along the continuum and show how this approach complements other methods in addressing the drug crisis.
In-person at the Colorow Building, Seminar Room 204, University of Utah (383 Colorow Way, Salt Lake City, UT) or on Zoom: Meeting ID: 810 3810 4237; passcode: [REDACTED]
Sponsored by the CTN Greater Intermountain Node.

NE Node Science Series: Meeting Teens Where They Are: Harnessing the Power of Digital Health Games to Impact Adolescent Behavioral Health
2025-10-16 09:00 - 10:00 (America/Los_Angeles) | Webinar/Virtual
In this webinar from the Northeast Node’s Science Series, Dr. Lynn E. Fiellin will discuss the:
Role of Digital Health Games, like those developed by the play2PREVENT Lab, which can serve as effective tools for addressing adolescent mental health and substance use challenges by engaging youth where they are and providing scalable, cost-effective interventions.
Impact of User-Centric Game Development and examine the importance of involving adolescents in the design and development process of health-focused video games, ensuring relevance and effectiveness through iterative feedback and collaboration.
Efficacy of Evidence-Based Interventions reviewing the methodologies and outcomes of randomized controlled trials conducted to assess the impact of digital health games on health behaviors, such as opioid misuse prevention and mental health promotion among high-risk adolescents.

AATOD (American Assoc. for the Treatment of Opioid Dependence) Conference 2025
2025-10-04 - 2025-10-08 | Philadelphia Marriott Downtown, 1201 Market St., Philadelphia, PA, 19107, United States
The 2025 American Association for the Treatment of Opioid Dependence, Inc. (AATOD) Conference will be held in Philadelphia, Pennsylvania at the Philadelphia Marriott Downtown, October 4-8, 2025. The 2025 conference theme is “The Evolving Field of Opioid Treatment.”
The intent is to educate and promote acceptance and integration of MAT options by patients, families, clinicians, the medical system, judicial systems, government, policymakers, social service administrations, and the general public. Presenters will disseminate innovative, evidence-based initiatives and treatment techniques to better serve patients and providers, improve program development and administration, promote integration across the continuum of care, and enhance patient outcomes to assist communities in developing an effective response to this crisis.

Greater Intermountain Node: Cannabis: Balancing Risk and Therapeutic Potential
2025-10-01 12:00 - 13:00 (America/Phoenix)
On the Rocks (OTR) is the Greater Intermountain Node’s (GIN) monthly Research Discussion Series, spotlighting standout addiction-related research from across the Greater Intermountain community. Designed for dynamic exchange, OTR fosters collaboration and fresh thinking through interactive conversations between presenters and attendees. The series name nods to the stunning Rocky Mountain backdrop and the iconic Utah trails just steps from our offices.

Join us for the next OTR on Wednesday, October 1, 2025, from 12–1 PM MST, featuring “Cannabis: Balancing Risk and Therapeutic Potential” with Marcel O. Bonn-Miller, PhD.

Dr. Bonn-Miller will share insights from three key research areas: Cannabis Use Disorder, the therapeutic promise of cannabinoids, and regulatory science. He’ll present findings on cannabis use among veterans with PTSD, explore cannabinoid-based treatments for sleep, anxiety, and substance use disorders, and discuss CBD safety standards and regulatory frameworks.

Dr. Bonn-Miller holds a BA and PhD in clinical psychology from the University of Vermont and completed a postdoctoral fellowship at Stanford. He launched his research career at the VA and University of Pennsylvania, later leading cannabis research in both academic and industry settings. He now serves as Chief Scientific Officer at Charlotte’s Web and has authored over 175 peer-reviewed publications.

Visit the OTR website to learn how to join. Free CME/CE credit available for live attendees.

CTN/ATTC Webinar: Characterizing Collegiate Recovery Programs: Findings from a Mixed Methods Study
2025-09-24 11:00 - 12:30 (America/Los_Angeles) | Webinar/Virtual
This presentation from Noel Vest, PhD, Assistant Professor at Boston University School of Public Health, will explore findings from a mixed-methods national study examining the structure, implementation, and impact of Collegiate Recovery Programs (CRPs) in the U.S. and Canada. Participants will learn about CRP funding models, mutual-help group (MHG) integration, and student recovery pathways, including key demographic trends and service utilization patterns. Drawing on both survey and qualitative data, the presentation will highlight barriers and facilitators to program success, with practical recommendations for expanding culturally competent and sustainable recovery support on college campuses.
1.5 CE/CME available.
Sponsored by the CTN Western States Node and the Northwest and Pacific Southwest ATTCs.

Guam's Sixth Annual Behavioral Health and Addictions Virtual Conference
2025-09-24 - 2025-09-25 | Webinar/Virtual
This live virtual conference is available at no-cost and will take place during National Recovery Month on September 24-25, 2025 (see time zone conversion chart within the agenda at-a-glance attached for days/times of presentations and workshops). All workshops are eligible for one (1) continuing education credit/contact hour, with select sessions eligible for one (1) CME or pharmacy credit/contact hour.
Sponsored by:
Guam Behavioral Health & Wellness Center (GBHWC) and the Pacific Southwest Addiction Technology Transfer Center (HHS Region 9)
Learn more and register here!

CTN Primary Care SIG: Engaging Primary Care in Research: Lessons from a High-Performing CTN Site
2025-09-22 12:00 - 13:00 UTC | Webinar/Virtual
The Primary Care SIG aims to engage primary care in research, develop substance use treatment interventions relevant to community-based practice, and promote the transfer of evidence-based results from substance use research into community-based practices.

Next Primary Care SIG Meeting:
“Engaging Primary Care in Research: Lessons from a High-Performing CTN Site”
September 22, 2025
12-1pm ET
Jennifer LaHue, MBA, BSN
Director of Strategic Initiatives, Clinical Informatics & Office-Based Addiction Treatment Program
Harris Health System

Zoom Information
Join the Zoom Meeting here!
Meeting ID: 947 8237 5156
Passcode: [REDACTED]

Interested in presenting at a future Primary Care SIG meeting? Email Sebastian Tong at setong@uw.edu or Claire Simon at clairebs@uw.edu

CTN Youth SIG: Leadership and Team Effectiveness for Implementation in Children's Mental Health
2025-09-19 11:00 - 12:00 (America/New_York) | Webinar/Virtual
This presentation from the CTN Youth SIG will focus on leadership, organizational, and team effectiveness implementation strategies. The design and results from multiple randomized leadership and organizational development trials will be presented. New emerging work on team effectiveness implementation approaches from the IN STEP Children’s Mental Health Research Center will be presented.
About the speaker:
Gregory Aarons, PhD, is a clinical and organizational psychologist specializing in implementation science for more than 25 years. He is currently Professor of Psychiatry at UC San Diego, Co-Director at UC San Diego ACTRI Dissemination and Implementation Science Center, and Director of the Child and Adolescent Services Research Center
Register for this session here!

CTN Quarterly Steering Committee Meeting
2025-09-16 13:30 - 16:00 (America/New_York) | Webinar/Virtual
Join us on September 16 (1:30-4pm ET) for the next CTN Quarterly Steering Committee Meeting!
Sessions will include final study reports for CTN-0099 and CTN-0096, an update from the RDC, and information about the CTN Coordination Hub. Find the agenda here.

Connect to the Teams meeting here
Meeting ID: 268 333 356 974
Passcode: [REDACTED]

CTN T&I SIG Meeting: Clinical Decision Support to Increase Provision of Opioid Use Disorder Services in Primary Care.
2025-09-16 09:00 - 10:00 (America/Los_Angeles) | Webinar/Virtual
In this session, Rebecca Rossom, MD, MS, Stephanie Hooker, PhD, MPH, and Gavin Bart, MD, PhD, FACP, DFASAM, will discuss the work of CTN-0095: Clinic-Randomized Trial of Clinical Decision Support for Opioid Use Disorders in Medical Settings. They will share their study approach, key findings, and lessons learned from implementing this pragmatic trial.
Contact Elena Rosenberg-Carlson at rosenbee@stanford.edu for the meeting link or to join the CTN T&I SIG listserv

Contingency Management: Implementation of a Highly Effective Intervention for the Treatment of Stimulant Use Disorder
2025-09-12 10:00 - 12:00 (America/Los_Angeles) | Webinar/Virtual
The UCLA Neuropsychiatric Institute and Hospital is celebrating its 50th anniversary. Please join the Greater Southern California Node for this free live virtual training on Friday September 12, 2025, from 10am to 12pm PST: Contingency Management: Implementation of Highly Effective Intervention for the Treatment of Stimulant Use Disorder.

Larissa Mooney, MD, Thomas E. Freese, PhD, and Richard A. Rawson, PhD, from UCLA’s Integrated Substance Use and Addiction Programs, Division of Addiction Psychiatry will be delivering the training.

Recent evidence indicates that methamphetamine and cocaine play a substantial and increasing role in the illicit drug crisis in the US—the 4th wave of the overdose crisis. The behavioral treatment known as contingency management (CM) has more than three decades of robust research supporting its efficacy for individuals with stimulant use disorder (StimUD). Despite overwhelming evidence supporting CM, it has not been widely used in routine treatment outside the VA healthcare system. This situation is changing as states are arranging insurance reimbursement for CM and developing CM programming for individuals with StimUD.

This presentation, provided by a team from UCLA Integrated Substance Use and Addiction Programs will begin with a brief overview of how cocaine and methamphetamine use are contributing to the current drug poisoning crisis. Presenters will review CM protocol elements, evidence for CM, current obstacles to widespread implementation of CM, and strategies for addressing barriers.

Presenters will also discuss the implementation strategies and preliminary results from the largest implementation of CM in publicly-funded treatment centers to date: The California Recovery Incentives Program. The project demonstrates the feasibility, replicability, and effectiveness of large-scale rollouts of this treatment. Time will be provided for audience Q&A and group discussion.

Continuing education credits ((CEs/CMEs/CEHs) are available! For more information about this event, check out the flyer.

Register for the session here!

OV Node Summer Speaker Series: Psychedelics as Therapeutics for Substances Use Disorder: A Perspective on Their Neurobiology and Future Clinical Applications
2025-08-13 12:00 - 13:00 (America/New_York) | Webinar/Virtual
Join the University of Cincinnati College of Medicine Center for Addiction Research, part of the CTN Ohio Valley Node, is hosting a Summer Speaker Series. The series will highlight cutting-edge UC addiction research and UC-community collaborations related to prevention and treatment.
The final event in the series will be held on August 13, 2025, from 12-1pm ET:
Psychedelics as Therapeutics for Substances Use Disorder: A Perspective on Their Neurobiology and Future Clinical Applications
August 13, 2025, 12-1pm ET
Host: T. John Winhusen, PhD, University of Cincinnati
Presenters:
Davide Amato, MSc, PhD, PD, University of Cincinnati
Jon Kostas, Association for Prescription Psychedelics
Register here!

GIN On the Rocks: Chronic Pain and Productive Activity in Post-9/11 Veterans: The Role of Separation Status, Military Occupation, and Sex Differences
2025-07-30 12:00 - 13:00 (America/Denver) | Webinar/Virtual
Join the Greater Intermountain Node On the Rocks on Wednesday, July 30, 2025 from 12-1 PM MST for the next installment of their “On the Rocks” monthly Research Discussion Series, “Chronic Pain and Productive Activity in Post-9/11 Veterans: The Role of Separation Status, Military Occupation, and Sex Differences,” presented by Kelsee M. Stromberg, PhD, MPH. Kelsee M. Stromberg, PhD MPH is a postdoctoral researcher in the University of Utah Program to Provide Pain Research Knowledge (UP3RK). She holds a PhD in Clinical and Translational Epidemiology from the University of Utah and an MPH from the University of New England. Her research focuses on the intersection of chronic pain and productive activity among post-9/11 U.S. military veterans, with an emphasis on understanding the role of social and sex differences in long-term functional outcomes. In this talk, Dr. Stromberg will discuss two ongoing projects that examine the implications of chronic pain, military separation context, and military occupational factors on productive activity outcomes among post-9/11 veterans. Her research explores how these service-related experiences influence reintegration into civilian roles. She will also address the co-occurring effects of mental health conditions, traumatic brain injury, posttraumatic stress disorder, and substance use disorder—factors that compound the challenges veterans face in achieving and sustaining engagement in work, education, and volunteering, and caregiving. To find out how to join, please visit the OTR website here. CME/CE credit available for free to all those who attend live!

CTN Primary Care SIG: Loneliness and SUD in Primary Care
2025-07-28 12:00 - 13:00 (America/New_York) | Webinar/Virtual
CTN Primary Care SIG

The Primary Care SIG aims to engage primary care in research, develop substance use treatment interventions relevant to community-based practice, and promote the transfer of evidence-based results from substance use research into community-based practices.

Join the SIG for their next meeting:
Loneliness and SUD in primary care

Sebastian Tong, MD, MPH
Associate Professor
Department of Family Medicine
University of Washington
Zoom link here!
Meeting ID: 958 7249 4214
Passcode: [REDACTED]

CTN Youth SIG: Neural Substrates of Risk-Reduction Interventions for Adolescents
2025-07-18 11:00 - 12:00 (America/New_York) | Webinar/Virtual
The CTN Youth SIG is pleased to invite you to an upcoming presentation/webinar:
Neural Substrates of Risk-Reduction Interventions for Adolescents
Presenter: Uma Rao, MD (University of CA, Irvine; Children’s Hospital of Orange County)
Adolescence is characterized by increased experimentation, which is helpful in the progression towards autonomy but also increases vulnerability to psychopathology. A temporal disassociation in the maturation of “socio-emotional” (reward) and “cognitive-control” (self-regulation) neural systems creates a period of poor decision-making and heightened vulnerability to risk-taking (reward-seeking) behavior with the onset of puberty. This presentation describes whether neural circuitry changes governing adolescent decision-making can be used to improve intervention programs seeking to deter risky behaviors, especially among African Americans who are disproportionately impacted by their negative consequences.
Register here!
Dr. Uma Rao is Professor of Psychiatry and Human Behavior at UC Irvine. Her research is focused on adolescent mood and substance use disorders, including neurobiological and psychosocial predictors of first onset and longitudinal clinical course of these disorders among at-risk youth (especially early-life adversity). In addition, she is involved in translational intervention research, examining biopsychosocial predictors of response to pharmacological and psychosocial interventions for these conditions.

OV Node Summer Speaker Series: Endocannabinoid Regulation of Repeated Stress-Cocaine Interactions
2025-07-09 12:00 - 13:00 (America/New_York) | Webinar/Virtual
Join the University of Cincinnati College of Medicine Center for Addiction Research, part of the CTN Ohio Valley Node, is hosting a Summer Speaker Series. The series will highlight cutting-edge UC addiction research and UC-community collaborations related to prevention and treatment.
The second event in the series will be held on July 9, 2025, from 12-1pm ET:
Endocannabinoid Regulation of Repeated Stress-Cocaine Interactions
July 9, 2025, 12-1pm ET
Host: T. John Winhusen, PhD (University of Cincinnati)
Presenter: Jayme McReynolds, PhD, University of Cincinnati
Register here!

Western States Node Webinar: CTN-0108: Transcranial Magnetic Stimulation in the Treatment of Stimulant Use Disorder
2025-06-25 11:00 - 12:30 UTC | Webinar/Virtual
In this session, Kathleen T. Brady, MD, PhD, of the Medical University of South Carolina, will discuss the NIDA N Clinical Trials Network (CTN) study CTN-0108, “Transcranial Magnetic Stimulation for the Treatment of Methamphetamine/Cocaine Use Disorder,” a pilot study that aims to determine the feasibility, effectiveness, and safety for 20 sessions of repetitive transcranial magnetic stimulation (rTMS) versus sham in adults with a diagnosed methamphetamine or cocaine use disorder.
Dr. Brady, co-Principal Investigator for CTN-0108, will present the rationale for the study, including the literature supporting the use of rTMS in stimulant use disorder, as well as the study methodology and preliminary results.
Objectives:

List 3 key research findings supporting the use of TMS in treating substance use disorders
Describe at least 3 key elements of the methodology for a trial of TMS in treating simulant use disorders
Identify at least 3 preliminary data points from the CTN-0108 study

CME and CE credits available! Sponsored by the Western States Node and the Northwest and Pacific Southwest ATTCs.
About the presenter:
Kathleen T. Brady, M.D., Ph.D.
Distinguished University Professor
Director, South Carolina Clinical and Translational Research Institute
Medical University of South Carolina
Dr. Brady is an experienced clinical and translational researcher and has been conducting scientific investigations and clinical work in the field of addictions and psychiatric disorders for over 40 years. Her focus is on pharmacotherapy and neurobiology of addictions, comorbid psychiatric disorders and gender differences in addictions. She has received numerous federal research grants and has published over 400 peer-reviewed journal articles and edited/co-edited 10 books. She is the former Vice President for Research at the Medical University of South Carolina. She has been a member of AAAP for over 25 years and has served at the President of the Association for Medical Education and Research in Substance Use Disorders (AMERSA), the American Academy of Addiction Psychiatry (AAAP) and is the immediate past president of International Society of Addiction Medicine (ISAM).

College on Problems of Drug Dependence (CPDD) Annual Meeting
2025-06-14 - 2025-06-18
CPDD provides a national and international forum for scientists of diverse backgrounds to advance the understanding of molecular-neurobiological aspects of addictive disorders and, by the application of new scientific knowledge, to improve and develop treatments utilizing novel behavioral and pharmacological therapies.
Since 1938, a major focus of the CPDD’s activities has been its sponsorship of an annual scientific meeting. This conference serves as a forum bringing together basic scientists and clinical investigators from industry, academia, and government. Representatives of regulatory agencies, as well as scientists and professionals in a number of diverse disciplines interested in the biochemical, behavioral, and public health aspects of drug dependence participate.
Approximately 1,300 attendees are expected for the 2025 meeting, including many international attendees who come for the CPDD meeting as well as the NIDA International Forum.

Northeast Node Science Series Webinar: Digital Tools to Promote Substance Use Disorder and Mental Health Care (June 12, 2025, 12pm ET)
2025-06-12 12:00 - 13:00 (America/New_York) | Webinar/Virtual
1.0 CME, ANCC, or Vermont OPR CE credits available!
Advances in digital technology, such as mobile devices, have fundamentally changed our society and are rapidly changing how we provide substance use and mental healthcare.
In this webinar from the CTN Northeast Node, part of their ongoing Science Series, Dr. Lisa Marsch, Director of the Dartmouth Center for Technology and Behavioral Health, will discuss how digital technology can provide state-of-the science, personalized behavioral healthcare anytime and anywhere.
She will review how data collected from mobile devices can provide new insights into the dynamic nature of substance use and mental health disorders in people’s daily lives and provide personalized digital therapeutic interventions to complement and extend our traditional models of care. She will highlight the striking behavioral healthcare needs across the globe and how digital technologies can help provide scalable solutions to tackle these population-level needs. She will provide a vision for the potential of digital technology to help redefine the future of behavioral healthcare.
Register for the session here!
